Go Pro

Nutex Health (NASDAQ:NUTX) Raised to Buy at Wall Street Zen

Nutex Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Nutex Health from “hold” to “buy,” bringing the stock’s consensus rating to “Buy” with an average price target of $317.50.
  • Nutex Health reported quarterly EPS of $9.38, exceeding the $4.95 consensus estimate, while revenue of $210.75 million fell slightly short of expectations.
  • The stock opened at $216.50 and has risen substantially from its 52-week low of $83.99; insiders own 44.68% of the company, while institutional ownership stands at 5.32%.
  • Five stocks we like better than Nutex Health.

Nutex Health (NASDAQ:NUTX - Get Free Report) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

Other research analysts have also issued research reports about the stock. B. Riley Financial restated a "buy" rating on shares of Nutex Health in a research report on Friday, September 4th. Lake Street Capital reiterated a "buy" rating and issued a $310.00 price target (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Zacks Research raised Nutex Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, August 24th. Finally, Weiss Ratings upgraded Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $317.50.

Check Out Our Latest Research Report on NUTX

Nutex Health Stock Up 2.0%

NUTX opened at $216.50 on Friday. Nutex Health has a fifty-two week low of $83.99 and a fifty-two week high of $224.28. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00. The company has a market capitalization of $1.48 billion, a P/E ratio of 8.50 and a beta of 0.55. The stock has a fifty day moving average of $188.64 and a 200-day moving average of $151.50.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, beating the consensus estimate of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The business had revenue of $210.75 million for the quarter, compared to the consensus estimate of $215.03 million. On average, equities analysts expect that Nutex Health will post 27.58 EPS for the current year.

Insider Buying and Selling at Nutex Health

In related news, Director Scott Saunders sold 203 shares of the company's stock in a transaction on Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the sale, the director directly owned 400 shares in the company, valued at $85,700. This represents a 33.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 44.68% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Kilter Group LLC acquired a new position in Nutex Health during the second quarter worth about $27,000. Islay Capital Management LLC acquired a new stake in shares of Nutex Health in the 4th quarter valued at approximately $34,000. Allworth Financial LP bought a new stake in shares of Nutex Health during the 2nd quarter valued at approximately $35,000. EverSource Wealth Advisors LLC bought a new stake in shares of Nutex Health during the 1st quarter valued at approximately $83,000. Finally, Mcguire Capital Advisors Inc. bought a new stake in shares of Nutex Health during the 4th quarter valued at approximately $165,000. Institutional investors own 5.32% of the company's stock.

About Nutex Health

(Get Free Report)

Nutex Health Inc is a physician-led healthcare company that operates an integrated network of micro hospitals, specialty hospitals and other healthcare facilities. Its care-delivery business provides emergency, inpatient and outpatient services designed to offer localized access to hospital care, particularly in communities that may be underserved by traditional hospital systems.

The company also operates a population health management business. Through affiliated physician networks and independent physician associations, Nutex Health provides services such as care coordination, utilization management and support for value-based care arrangements.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines